BioCentury
ARTICLE | Financial News

ImmunoMet Therapeutics completes venture financing

March 9, 2017 12:49 PM UTC

On March 7, immuno-oncology company ImmunoMet Therapeutics (Houston, Texas) raised $5 million in a series B round. New investors Intervest, SL Investment and NHN Investment and existing investors Mira...

BCIQ Company Profiles

ImmunoMet Therapeutics Inc.